Lantern Pharma Inc. Earnings Per Share (Basic)
Lantern Pharma Inc. (LTRN) reported Earnings Per Share (Basic) of -$0.57 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- Lantern Pharma Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.57.
- Lantern Pharma Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.30.
- Lantern Pharma Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.39.
- Lantern Pharma Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.40.
- Lantern Pharma Inc. earnings per share, basic for fiscal 2025 was -$1.57.
- Lantern Pharma Inc. earnings per share, basic for fiscal 2024 was -$1.93.
- Lantern Pharma Inc. earnings per share, basic for fiscal 2023 was -$1.47.
- Lantern Pharma Inc. earnings per share, basic for fiscal 2022 was -$1.31.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.57 10-Q · filed 2026-08-14 | -$0.88 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | -$0.30 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | -$1.57 10-K · filed 2026-03-30 | |||
| 2025-09-30 | -$0.39 10-Q · filed 2025-11-12 | -$1.21 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | -$0.40 10-Q · filed 2026-08-14 | -$0.82 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | -$0.42 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | -$1.93 10-K · filed 2026-03-30 | |||
| 2024-09-30 | -$0.42 10-Q · filed 2025-11-12 | -$1.39 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$0.46 10-Q · filed 2025-08-13 | -$0.97 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$0.51 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$1.47 10-K · filed 2025-03-27 | |||
| 2023-09-30 | -$0.29 10-Q · filed 2024-11-07 | -$1.08 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | -$0.44 10-Q · filed 2024-08-08 | -$0.79 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$0.36 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$1.31 10-K · filed 2024-03-18 | |||
| 2022-09-30 | -$0.21 10-Q · filed 2023-11-08 | -$1.00 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | -$0.41 10-Q · filed 2023-08-09 | -$0.79 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | -$0.38 10-Q · filed 2023-05-09 | -$0.70 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$1.06 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$1.26 derived: net income ÷ weighted average shares · filed 2023-05-09 |
| 2021-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2023-03-20 | -$0.68 derived: net income ÷ weighted average shares · filed 2023-03-20 | -$0.89 derived: net income ÷ weighted average shares · filed 2023-03-20 | -$1.13 10-K · filed 2023-03-20 |
| 2021-09-30 | -$0.36 10-Q · filed 2022-11-07 | -$0.57 derived: net income ÷ weighted average shares · filed 2022-11-07 | -$0.82 10-Q · filed 2022-11-07 | |
| 2021-06-30 | -$0.21 10-Q · filed 2022-08-08 | -$0.45 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$0.24 10-Q · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |